Tej Virk's guest appearances

Tej Virk

The Cannabis Conversation | Medical Cannabis | CBD | Hemp

Professionally Cannabis & Psychedelics

Nikolay Tretiyakov

Mitchell Osak

Tim Phillips

David Badcock

Tim Shu

Deepak Anand

Mark Reinders

Tjalling Erkelens

Alan Brochstein

Bek Muslimov

Ethan Russo

Bruce Linton

Max Simon

Aras Azadian

Dedi Meiri

OwlTail

On this week's episode, we welcome back Tej Virk, CEO of Akanda Corp - integrated medical cannabis company with operations in Africa and the UK.We examine the importance of ESG investments within the cannabis world, the opportunities they can bring, and the challenges that exist in this area.About Tej Virk​​Tej Virk is the CEO and Director of Akanda, an international medical cannabis company, cultivating ethically sourced cannabis in Lesotho. He started his career in investment banking, spending 15 years with BMO Capital Markets, with his final year focusing heavily on the cannabis industry. He transacted on over 100 IPOs and follow-on capital raises, including companies such as Canopy Growth Corp. and Tilray, before joining Canopy Growth Corp. in 2019, as Managing Director of Europe where he drove the multinational expansion of Canopy's European operations.  Virk then joined Khiron Life Sciences as President of Europe where he established the company’s European medical and consumer packaged goods business from scratch.Virk has earned a reputation for industry leading innovation and successful execution in the global cannabis space, including overseeing multiple European pharmaceutical and consumer product launches, bleeding-edge regulatory work, accreditation of medical education platforms for health care providers, e-commerce rollouts, multiple sector M&amp;As, establishing telemedicine partnerships, and setting up supply chains and distribution channels in every continent. Virk was a founding member and executive group stakeholder for Project Twenty21, the UK’s largest medical cannabis study. The study published the first real-world data collected on medical cannabis in the UK, with findings indicating that legally prescribed cannabis provides clinically significant improvements in the quality of life of patients living with numerous medical conditions.Quotables‘I like to make a positive impact on society. That was one of my reasons for leaving the banking industry to to join the cannabis industry’ 4:42ResourcesAkanda Corp’s Website: https://akandacorp.com/Follow Akanda Corp on Instagram: https://www.instagram.com/akandacorp/?hl=enFollow Akanda Corp on Twitter:https://twitter.com/akandacorpJoin Tej on LinkedIn:https://www.linkedin.com/in/tej-virk-52403769/?originalSubdomain=ukFollow Tej on Instagram: https://www.instagram.com/tvlondon/?hl=enFollow Tej on Twitter: https://twitter.com/tejvirkceo?lang=en

On this week's episode, we welcome back Tej Virk, CEO of Akanda Corp - integrated medical cannabis company with operations in Africa and the UK.We examine the importance of ESG investments within the cannabis world, the opportunities they can bring, and the challenges that exist in this area. About Tej Virk​​Tej Virk is the CEO and Director of Akanda, an international medical cannabis company, cultivating ethically sourced cannabis in Lesotho. He started his career in investment banking, spending 15 years with BMO Capital Markets, with his final year focusing heavily on the cannabis industry. He transacted on over 100 IPOs and follow-on capital raises, including companies such as Canopy Growth Corp. and Tilray, before joining Canopy Growth Corp. in 2019, as Managing Director of Europe where he drove the multinational expansion of Canopy's European operations.  Virk then joined Khiron Life Sciences as President of Europe where he established the company’s European medical and consumer packaged goods business from scratch.Virk has earned a reputation for industry leading innovation and successful execution in the global cannabis space, including overseeing multiple European pharmaceutical and consumer product launches, bleeding-edge regulatory work, accreditation of medical education platforms for health care providers, e-commerce rollouts, multiple sector M&amp;As, establishing telemedicine partnerships, and setting up supply chains and distribution channels in every continent. Virk was a founding member and executive group stakeholder for Project Twenty21, the UK’s largest medical cannabis study. The study published the first real-world data collected on medical cannabis in the UK, with findings indicating that legally prescribed cannabis provides clinically significant improvements in the quality of life of patients living with numerous medical conditions. Quotables‘I like to make a positive impact on society. That was one of my reasons for leaving the banking industry to to join the cannabis industry’ 4:42 ResourcesAkanda Corp’s Website: <a href="https://akandacorp.com/" rel="nofollow" target="_blank">https://akandacorp.com/</a>Follow Akanda Corp on Instagram: <a href="https://www.instagram.com/akandacorp/?hl=en" rel="nofollow" target="_blank">https://www.instagram.com/akandacorp/?hl=en</a>Follow Akanda Corp on Twitter:<a href="https://twitter.com/akandacorp" rel="nofollow" target="_blank">https://twitter.com/akandacorp</a>Join Tej on LinkedIn:<a href="https://www.linkedin.com/in/tej-virk-52403769/?originalSubdomain=uk" rel="nofollow" target="_blank">https://www.linkedin.com/in/tej-virk-52403769/?originalSubdomain=uk</a>Follow Tej on Instagram: <a href="https://www.instagram.com/tvlondon/?hl=en" rel="nofollow" target="_blank">https://www.instagram.com/tvlondon/?hl=en</a>Follow Tej on Twitter: <a href="https://twitter.com/tejvirkceo?lang=en" rel="nofollow" target="_blank">https://twitter.com/tejvirkceo?lang=en</a>

EPISODE #137 ESG and The Cannabis Industry with Tej Virk, CEO at Akanda Corporation

Tune in to this week's pod to hear insights from the President of Europe for Khiron Life Sciences, a Canadian-based cannabis LP with major facilities and operations in Colombia.   Tej takes us through how their recently acquired certifications and licenses will help to provide cannabis medicines to thousands in Colombia, Khiron’s European footprint within the medical cannabis market, and how telemedicine is going to increase patient access during this global pandemic and beyond. Take a look at the full collection of podcasts and explore additional cannabis &amp; psychedelics content at: https://contenthub.gcintelligence.com/

Tune in to this week's pod to hear insights from the President of Europe for Khiron Life Sciences, a Canadian-based cannabis LP with major facilities and operations in Colombia.   Tej takes us through how their recently acquired certifications and licenses will help to provide cannabis medicines to thousands in Colombia, Khiron’s European footprint within the medical cannabis market, and how telemedicine is going to increase patient access during this global pandemic and beyond. Take a look at the full collection of podcasts and explore additional cannabis &amp; psychedelics content at: <a href="https://contenthub.gcintelligence.com/" rel="nofollow" target="_blank">https://contenthub.gcintelligence.com/</a>

Tej Virk, President of Europe at Khiron Life Sciences